Drug intelligence / Profile preview

Pudilan Xiaoyan Tablets

Development stage
Unknown
Lead developer
Guangdong Xinbao Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Pudilan Xiaoyan Tablets is a traditional Chinese medicine (TCM) oral formulation developed and manufactured by Guangdong Xinbao Pharmaceutical. It is a combination product consisting of extracts from four primary medicinal herbs: *Herba Taraxaci* (Dandelion), *Herba Violae* (Violet), *Radix Isatidis* (Isatis root), and *Radix Scutellariae* (Baikal skullcap). The drug is widely utilized in China for its heat-clearing, detoxifying, and anti-inflammatory properties. It is primarily indicated for the treatment of inflammatory conditions of the upper respiratory tract, such as acute tonsillitis, pharyngitis, and laryngitis, as well as for skin infections like boils and carbuncles. The therapeutic effect is attributed to the synergistic action of its herbal components, which exhibit broad-spectrum antibacterial and antiviral activities, alongside the inhibition of pro-inflammatory mediators.

Brand names
Pudilan Xiaoyan Tablets
Other names
Pudilan Xiaoyan Pian蒲地蓝消炎片
02

Targets

NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)HSP90AA1 (Heat shock protein HSP90-alpha)ESR1 (ERα)

Beyond the preview

Go deeper on Pudilan Xiaoyan Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pudilan Xiaoyan Tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call